As previously reported, Wedbush downgraded NutriSystem to Neutral from Outperform. The firm downgraded shares citing increased discounting and lack of consumer demand for new offerings. Price target lowered to $11 from $15. :theflyonthewall.com
News For NTRI From The Last 14 Days
Check below for free stories on NTRI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
